Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 7.


Lewis, Gavin A, Rosala-Hallas, Anna ORCID: 0000-0001-8012-9995, Dodd, Susanna ORCID: 0000-0003-2851-3337, Schelbert, Erik B, Williams, Simon G, Cunnington, Colin, McDonagh, Theresa and Miller, Christopher A
(2022) Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11 (14). e024668-.


Bradley, Joshua, Schelbert, Erik B, Bonnett, Laura J ORCID: 0000-0002-6981-9212, Lewis, Gavin A, Lagan, Jakub, Orsborne, Christopher, Brown, Pamela Frances, Black, Nicholas, Naish, Josephine H, Williams, Simon G
et al (show 3 more authors) (2023) Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation. HEART, 110 (3). pp. 195-201.


Lewis, Gavin A, Rosala-Hallas, Anna ORCID: 0000-0001-8012-9995, Dodd, Susanna ORCID: 0000-0003-2851-3337, Schelbert, Erik B, Williams, Simon G, Cunnington, Colin, McDonagh, Theresa and Miller, Christopher A
(2022) Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection Fraction. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 15 (6). pp. 1436-1443.


Lewis, Gavin A, Schelbert, Erik B, Naish, Josephine H, Bedson, Emma, Dodd, Susanna ORCID: 0000-0003-2851-3337, Eccleson, Helen, Clayton, Dannii ORCID: 0000-0003-3535-3466, Jimenez, Beatriz Duran, McDonagh, Theresa, Williams, Simon G
et al (show 8 more authors) (2019) Pirfenidone in Heart Failure with Preserved Ejection Fraction-Rationale and Design of the PIROUETTE Trial. CARDIOVASCULAR DRUGS AND THERAPY, 33 (4). pp. 461-470.


Lewis, Gavin A, Dodd, Susanna ORCID: 0000-0003-2851-3337, Clayton, Dannii ORCID: 0000-0003-3535-3466, Bedson, Emma, Eccleson, Helen, Schelbert, Erik B, Naish, Josephine H, Jimenez, Beatriz Duran, Williams, Simon G, Cunnington, Colin
et al (show 7 more authors) (2021) Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial. NATURE MEDICINE, 27 (8). 1477-+.


Bradley, Joshua, Schelbert, Erik B, Bonnett, Laura J ORCID: 0000-0002-6981-9212, Lewis, Gavin A, Lagan, Jakub, Orsborne, Christopher, Brown, Pamela F, Naish, Josephine H, Williams, Simon G, McDonagh, Theresa
et al (show 2 more authors) (2022) Predicting hospitalisation for heart failure and death in patients with, or at risk of, heart failure before first hospitalisation: a retrospective model development and external validation study. LANCET DIGITAL HEALTH, 4 (6). E445-E454.


Lewis, Gavin A, Rosala-Hallas, Anna ORCID: 0000-0001-8012-9995, Dodd, Susanna ORCID: 0000-0003-2851-3337, Schelbert, Erik B, Williams, Simon G, Cunnington, Colin, McDonagh, Theresa and Miller, Christopher A
(2022) Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction. The International Journal of Cardiovascular Imaging, 38 (7). pp. 1569-1578.

This list was generated on Tue Feb 6 17:25:37 2024 GMT.